Fig. 3From: A pan-cancer analysis of Dyskeratosis congenita 1 (DKC1) as a prognostic biomarkerDKC1 mutant alterations in different cancers based on TCGA. A The alteration frequency in different cancers with different mutation types. B DKC1 mutation sites. The mutation site with the highest mutant cases was marked. C The 3D structure of DKC1 protein. D The disease-free survival, disease-specific survival, overall survival, and progression-free survival of DKC1 mutant status in UCEC cases. E UCEC samples with DKC1 mutation in TCGA datasetBack to article page